Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Commercial Sponsor
AbbVie
Scientific Title
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Of Navitoclax In Combination With Ruxolitinib Versus Ruxolitinib In Subjects With Myelofibrosis (TRANSFORM-1)